These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Renin inhibitors--new direction in the treatment of arterial hypertension].
    Author: Vasiuk IuA, Sadulaeva IA, Iushchuk EN, Trofimenko OS, Chirkov MV, Fedoseeva VS, Kulikov KG.
    Journal: Ter Arkh; 2010; 82(9):53-9. PubMed ID: 21086622.
    Abstract:
    The paper covers current problems in the treatment of arterial hypertension. Renin is an important and promising therapeutic target. The direct renin inhibitor aliskiren (Rasilez) is a promising current effective antihypertensive agent that has cardio- and nephroprotective effects. The paper considers a number of clinical studies that have proven the antihypertensive effect of aliskiren and revealed its benefits versus other drugs recommended for blood pressure lowering. It is assumed that this agent may be used in combinations with angiotensin-converting enzyme inhibitors, thiazide or thiazide-like diuretics, and calcium antagonists. Moreover, aliskiren neutralizes the effect of feedback in the compensatory increase in the activity of plasma renin.
    [Abstract] [Full Text] [Related] [New Search]